Hostname: page-component-78c5997874-s2hrs Total loading time: 0 Render date: 2024-11-05T03:36:35.140Z Has data issue: false hasContentIssue false
  • English
  • Français

Citicoline for traumatic brain injury: Report of two cases, including my own

Published online by Cambridge University Press:  01 March 1999

PAUL A. SPIERS  and
GAIL HOCHANADEL
PAUL A. SPIERS
Affiliation:
Clinical Research Center, Massachusetts Institute of Technology
GAIL HOCHANADEL
Affiliation:
Clinical Research Center, Massachusetts Institute of Technology
Get access Rights & Permissions [Opens in a new window]

Abstract

Citicoline is an investigational new drug in this country that was provided on a compassionate use basis in two cases of traumatic brain injury after horseback riding accidents. While this report is primarily anecdotal, the behavioral observations in both cases suggested atypical patterns of improvement and perhaps greater recovery than might otherwise have been predicted. The side effect profile of this drug is negligible and previous experimental research has yielded positive findings for treatment after stroke and head trauma, as well as memory loss in aging. Consequently, Citicoline may potentially be very helpful for patients suffering traumatic brain injuries and should, in our opinion, be made available and studied further in this clinical population. (JINS, 1999, 5, 260–264.)

Keywords

CiticolineBrain injuryHead traumaRecovery
Type
CASE STUDY
Information
Journal of the International Neuropsychological Society , Volume 5 , Issue 3 , March 1999 , pp. 260 - 264
Copyright
© 1999 The International Neuropsychological Society

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)